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A B S T R A C T
Tuberculoma involving the cavernous sinus is a rare presentation of CNS disease, with only twelve cases
reported in previous literature. We report a case of a 48 year old woman who presented with a right
cavernous sinus syndrome of 2 months duration. MRI showed a mass in the right cavernous sinus, and
serologic workup revealed an elevated sedimentation rate and positive Quantiferon1-GOLD testing. 18-
FDG PET-CT demonstrated a hypermetabolic 3 cm subcarinal lymph node, and lymph node biopsy
showed caseating granuloma. Culture of lymphatic tissue grew drug-sensitive M. tuberculosis. The
patient was treated with a non-standard 4-drug regimen and prednisone, with rapid improvement of
symptoms and radiologic abnormalities. Total length of treatment was 12 months. In addition, we
review the 12 cases found in literature, and discuss clinical features, diagnostic dilemmas, and
approaches to treatment.
 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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Tuberculosis is capable of a wide variety of intracranial
presentations including meningeal and intracerebral or parenchy-
mal disease. Tuberculomas are usually found in the cerebral
hemispheres, and thought to arise by hematogenous spread [1].
Cavernous sinus involvement is rare; only 12 cases have been
reported in the English language literature since 1992 [2–14]. The
presentation may mimic meningioma, and has often been found
only after surgical resection of the lesion. Diagnosis without biopsy
is often based on the ﬁnding of Mycobacterium tuberculosis in other
sites.
We report a case of presumed tuberculoma of the cavernous
sinus that was diagnosed by biopsy of another extrapulmonary
site, identiﬁed by PET-CT scanning, in a previously healthy, U.S.
born individual.
Case report
A 48 year old woman presented to her ophthalmologist with
complaints of headache and double vision. She ﬁrst noticed
diplopia two months prior to evaluation, which waxed and waned
in intensity. One month later, she had recurrent severe diplopia,
most prominent on rightward gaze, accompanied by nausea,
headache, and photophobia. Her symptoms persisted and* Corresponding author.
E-mail address: shk9078@nyp.org (S. Kapadia M.D.).
http://dx.doi.org/10.1016/j.idcr.2014.10.010
2214-2509/ 2014 The Authors. Published by Elsevier Ltd. This is an open access articl
3.0/).progressed to include and right-sided eyelid heaviness. The patient
was previously healthy, born in New York City, and had worked in
maintenance.
Neurologic exam revealed right ptosis, sluggish pupil, lateral
gaze palsy, and diminished medial as well as downward gaze. She
also had hypoesthesia in the V2 distribution. The patient was
afebrile and had no meningeal signs. She had no pulmonary
symptoms.
Results of complete blood count, routine chemistry, comple-
ment testing, and serum ACE were normal. Sedimentation rate was
elevated at 49. MRI of the brain was performed, showing an
enhancing lesion in the right cavernous sinus (Fig. 1). A
Quantiferon1-GOLD test was performed as part of the initial
work-up, and returned positive (Nil 0.046, TB Ag > 10,
Mitogen > 10, TB-Nil > 10).
Result of chest X-ray and HIV testing were negative. 18-FDG
PET-CT was performed to assess for additional disease sites that
would be more amenable to biopsy. PET-CT cuts in the chest
revealed a subcarinal mass with intense uptake (SUV of 11). Biopsy
of the subcarinal lymph node was performed using a robotic VATS
procedure. Lymph node pathology revealed both necrotizing and
non-necrotizing granulomas, and cultures subsequently grew
M. tuberculosis, susceptible to all ﬁrst-line drugs. The patient
was started on therapy with INH 300 mg daily, rifampin 600 mg
daily, pyrazinamide 1500 mg daily, and levoﬂoxacin 750 mg daily.
Ethambutol was not given because of concern for potential ocular
toxicity, given her cranial nerve deﬁcits and diplopia. She was also
treated with daily prednisone. Pyrazinamide was discontinued ine under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/
Fig. 1. Initial MRI showing an enhancing lesion in the right cavernous sinus exerting
mass effect and narrowing the cavernous segment of the right internal carotid
artery.
Fig. 2. MRI after completion of therapy showing resolution of the previously
described lesion.
S. Kapadia M.D., A. Patrawalla M.D. / IDCases 1 (2014) 97–100983 months, and levoﬂoxacin in four months. She was treated with
INH and rifampin to complete a 12 month course.
The patient’s gaze palsies improved while on therapy, though
her facial hypoesthesia persisted. Repeat MRI 3 months into
treatment showed improvement of cavernous sinus lesion. MRI
after treatment showed near-complete resolution of the lesion
(Fig. 2).
Discussion
While accounting for about 5% of all extrapulmonary TB in the
United States, CNS tuberculosis can be among the most
challenging and difﬁcult to treat [15]. The clinical syndromes
include meningitis, abscess formation or tuberculoma [1]. Tuber-
culoma accounts for between 10 and 30% of cases of CNS disease,
though the reported frequency varies. The majority of cases
involve the cerebral hemispheres [1,7,16]. Despite the propensity
to affect the hemispheres, unusual locations of CNS tuberculoma
continue to be reported, including the cerebropontine angle, the
sellar and suprasellar regions, and as in our case, the cavernous
sinus [9].
Diagnosis of cavernous sinus tuberculoma is complex. While
radiographic features have been described depending on the
level of necrosis, differentiating tuberculoma from tumor on
imaging alone remains difﬁcult [5]. In a majority of cases of
cavernous sinus tuberculosis, the diagnosis was reached only
after surgical biopsy of the lesion, often due to suspicion of
meningioma [4–14]. Other cases, including our case above, were
diagnosed after testing revealed evidence of tuberculosis at
extra-CNS sites [2,3]. Molecular methods including PCR testing
and potentially GeneXpert MTB/RIF may also have a role in
diagnosis, though they have not been used in any of the below
cases. Proton MR spectroscopy, diffusion weighted MRI, anddynamic contrast enhanced MRI may also be useful as adjunctive
imaging tests that can increase the speciﬁcity of the diagnosis
[4,5,9].
The need for surgery in diagnosis depends largely on whether
or not noninvasive testing yields a diagnosis. The diagnostic
approach suggested by the British Infectious Society for
suspected tuberculoma recommends a thorough search for
AFB in the CSF, as well as PCR and nucleic acid ampliﬁcation
testing. A careful search for extra-CNS sites should be undertak-
en, and consideration for imaging of chest and abdomen to seek
an easily accessible source of tissue [17]. Our case demonstrated
the utility of PET-CT in ﬁnding an alternative site of disease. In
many cases, the diagnosis remains unclear, and histological
evaluation is ultimately required [9]. Often, this can be done
safely via stereotactic biopsy [18].
Review of literature found 12 reported cases of tuberculosis
in the cavernous sinus other than our own, with 2 of those
cases localizing to Meckel’s cave (see Table 1). Epidemiologic
features are inconsistently reported, but 8 of the 13 total cases
were found to be HIV negative. Ten cases were diagnosed based
on operative removal of the tumor and resultant pathology. It is
notable that none of the biopsied intracranial tumors had
reported AFB smear positivity and none had culture positivity
for M. tuberculosis. Of the remaining cases, Al Soub reports
diagnosis of tuberculosis based on a positive sputum culture [2],
Bafna reports a case based on culture of a cervical lymph node
[3], and our case was diagnosed based on culture of a subcarinal
lymph node.
Treatment of tuberculoma follows that of CNS tuberculosis in
general: 4-drug antituberculous therapy in a 2-month intensive
phase followed by 2 drug therapy for a continuation phase to
complete a 9–12 month course [17,19]. The choice of drugs for
sensitive M. tuberculosis infection typically include isoniazid and
rifampin as well as pyrazinamide. The optimal fourth drug remains
unclear: streptomycin and ethambutol are frequently recom-
mended. The former runs risk of renal toxicity as well as frequent
resistance, and the latter may result in concerning ocular toxicity.
Both drugs are shown to have poor CNS penetration, making their
therapeutic role unclear [20]. Fluoroquinolones are another
option; though not as well established, CNS penetration appears
Table 1
Table of cases.
Source Year Age Ethnicity Gender Symptoms Imaging: Diagnosis: PPD AFB
smear
TB culture Tx Response HIV DM
Morris 1992 42 Filipino F Headache, facial pain,
L CN V deﬁcit
Left cavernous sinus
lesion
Operative removal
revealing granulomas
þ – Negative INH 300/d, rifampin
600/d, PZA 25/kg/d,
pyridoxine 50/g
Continued CNVII
palsy, resolution of
eye deﬁcits
Negative
Phookan 1995 33 "Asian" M Headache, diplopia,
ptosis, facial pain,
opthalmoplegia,
dilated left pupil
Left cavernous sinus
lesion
Operative removal
revealing granuloma
– INH 300/d, rifampicin
600/d, ethambutol 1g/
d, PZA 1g/bid,
pyridoxine 10/d
Improved at 2 years
follow up but not
resolved, unclear
how long he was
treated
Bafna 1997 65 F Periorbital pain and
ptosis of the right eye,
ophthalmoplegia on
right
Right cavernous
sinus fullness
Cervical LN biopsy + M tuberculosis INH/Rifampin/
Ethambutol/PZA, +
methylprednisolone
Partial improvement
of ptosis and motility
at 6 weeks, imaging
improvement
Yes
Grayeli 1998 48 Black African M Headache for 2
months, left eye
ptosis, left upward
and medial gaze
deﬁcit, hemifacial
hypethesia, abolished
left blink
Lateral left cavernous
sinusmass extending
medially
Operative removal
revealing granuloma,
CXR with sequelae of
old TB
– Negative Rifampin, ethambutol,
INH
Resolution of
symptoms and
improved imaging
Negative
Goel 1999 35 F Headache for 1 year,
left facial paresthesia,
left gaze diplopia,
wasting of temporalis
and masseter on left,
left CN V, VI deﬁcit
Tumor in posterior
cavernous sinus,
petroud apex
Operative removal
revealing tuberculoma
– Antitubercular therapy
for 18 months
Resolution of
symptoms and
improved imaging
Negative
Al Soub 2001 44 Thai M Headache, periorbital
pain, ptosis,
ophthalmoplegia,
dilated L pupil
Left cavernous sinus
fullness
Sputum culture with
Mtb
– – M tuberculosis INH 300/d, rifampin
600/d, PZA 1.5g/d,
ethambutol 800/d,
pyridoxine 40/g x 2
months, then rifampin
+ INH x 10 months,
prednisolone 60mg
daily x 1 month
Resolution of
symptoms and
improved imaging
Negative No
Rebai 2001 44 F Headache for 1
month, right ptosis,
horizontal diplpia,
right CN III, CN V, CN
VI deﬁcit
Right laterosellar
mass overlapping the
sella turcica and
clivus
Biopsy of leson
performed revealing
tuberculoma
Rifampicin, INH,
ethambutol for 1 year
Resolution of
ophthalmoplegia and
CN V, improved
imaging
Hui 2002 48 M Headache and double
vision x 2weeks, R eye
abduction deﬁcit,
absent right corneal
reﬂex, right eye ptosis,
R CN III, IV, V, VI deﬁcit
Right cavernous
sinus lesion
extending to right
temporal lobe
Operative removal
revealing granuloma
– Negative "12 months TB
therapy"
Residual right
abducens nerve palsy
No
Yanardag 2005 36 M Headache for 2
months, ptosis,
diplopia, medial,
upward and lateral
left gaze deﬁcit, left
hemifacial
hypoaesthesia in CN
V1 area
Left cavernous sinus
mass
Operative removal
revealing granuloma
– Negative INH, rifampin,
theambutol
MR improved at 2
months, symptoms
improved at 4
months
Negative No
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S. Kapadia M.D., A. Patrawalla M.D. / IDCases 1 (2014) 97–100100to be good [17]. Levoﬂoxacin was chosen as a fourth agent in this
case both for improved CNS penetration as well as reduced chance
of ocular toxicity.
The role of adjunctive steroids for tuberculoma is unclear.
Though recommended strongly for tuberculous meningitis, their
beneﬁt in CNS tuberculoma has not been shown in controlled
trials [17]. Only 4 of the cases of cavernous sinus tuberculosis,
including ours, reported use of adjunctive corticosteroids. The
rationale for corticosteroid treatment includes possible reduction
of symptoms as well as prevention of paradoxical expansion of the
tuberculoma [9].
The proportion of extrapulmonary TB in the US is rising and
appears to have different risk factors than pulmonary TB. Our case,
which adds to the small number of reported cases of cavernous
sinus tuberculomas, demonstrates how EPTB can present atypi-
cally. This case, which lacks the usual risk factors, highlights the
need for vigilance in low-prevalence settings and with EPTB in
general. While diagnosis is difﬁcult and often delayed, a careful
search for extracranial sites of disease can lead to earlier and safer
histopathological conﬁrmation. We also demonstrate how PET-CT
as an imaging modality can assist in identifying an alternate site
amenable to biopsy, avoiding the need for a more invasive brain
biopsy. Antitubercular therapy is effective in these cases, and
adjunctive steroids are frequently included, but long-term clinical
and radiologic follow-up are essential in securing a good outcome.
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